Access Market Intelligence

Top 5 pipeline drugs for 2018New blockbuster drugs to treat various conditions are expected to be among the top drugs to hit the marketplace in 2018. Here are 5 of the top new drugs in the pipeline for 2018, according to analysts.
Will price impede recently approved implant for opioid addicts?Probuphine implant could be a new option for addicts if obstacles, such as price, don’t get in the way.
Novartis signs on to value-based pricing for EntrestoHospitalizations represent up to 80 percent of the direct medical costs of heart failure; reducing heart failure hospitalizations can help bring down overall healthcare costs.
Oncology drugs in the pipelineSeveral new drugs hold promise, but cost is a top concern.
Proposed Medicaid rule: 7 things health execs should knowThe Centers for Medicare & Medicaid Services (CMS) proposed to modernize Medicaid and Children’s Health Insurance Program (CHIP) managed care regulations to update the programs’ rules and strengthen the delivery of quality care for beneficiaries. This proposed rule is the first major update to Medicaid and CHIP managed care regulations in more than 10 years.
FDA moves forward with approval of generic Abilify from 4 different manufacturers despite Otsuka pushbackFDA’s approval of generic versions of Abilify (aripiprazole), an antipsychotic drug approved to treat schizophrenia and bipolar disorder, from 4 different generic manufacturers, has industry insiders pondering the generic drug market.
Be vigilant of counterfeit version of Botox found in United StatesA counterfeit version of onabotulinumtoxinA (Botox) was found in the United States and may have been sold to doctors’ offices and medical clinics nationwide. The version is considered unsafe and should not be used.
[BLOG]: Biosimilar confusion and insightsSince Virginia became the first state in May 2013 to enact legislation regulating a pharmacist’s substitution of an interchangeable biologic drug for a prescribed reference biologic drug, there has not been much activity or clarity on the issue.
CVS: Expansion of MinuteClinics to offset tobacco revenue lossIn an increasing effort to continue to play a complementary role with primary care practices in providing care to patients, CVS Health has worked to deplete existing cigarette inventory at CVS/pharmacy stores without receiving new shipments.
CVS: Expansion of MinuteClinics to offset tobacco revenue lossIn an increasing effort to continue to play a complementary role with primary care practices in providing care to patients, CVS Health has worked to deplete existing cigarette inventory at CVS/pharmacy stores without receiving new shipments.